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Abstract
The C19-YRS was the first scale reported in the literature for patient assess-
ment and monitoring in Long Covid or Post-COVID syndrome. The scale 
has demonstrated content validity in a previous COVID-19 follow-up study. 
The growing number of patients with Post-COVID syndrome required the 
development of a self-report version (and a digital format) so that the 
scale can be completed by patients themselves. Individuals with Long 
Covid and clinicians providing care were involved in iterative changes to 
the scale. The self-report version of the scale captures symptom severity, 
functional disability and global health status. The C19-YRS digital format 
comprises a smartphone application for the patient and a web portal for 
the clinician to assess, triage and monitor patients remotely. The items 
have been shown to span all the components of the WHO ICF Framework 
for health condition.
Introduction
Long Covid (LC) refers to persistent symptoms four weeks after contracting 
COVID-19 illness and Post-COVID syndrome refers to symptoms 12 weeks 
after the illness.1 There are an estimated more than 400,000 cases of 
Post-COVID syndrome in the UK alone and more than five million cases 
worldwide.1 More than 200 symptoms across 10 organ systems have been 
reported with most common symptoms being breathlessness, fatigue, 
palpitations, dizziness, pain, brain fog (cognitive problems), anxiety, 
depression, post-traumatic stress, skin rash and allergic reactions.2 It is a 
remitting and relapsing condition with a protracted course causing signifi-
cant distress and disability to the individual. 
A multidisciplinary team (MDT) of rehabilitation professionals quickly 
identified the need to address the essential issue of following up COVID-19 
patients after hospital discharge during the first wave of the pandemic. 
As face-face appointments were deemed risky, the team recognised 
the requirement for virtual assessment of these patients.3,4 A telephone 
screening scale, the C19-YRS, was developed based on staff experience 
of managing these patients and knowledge from our systematic review of 
previous outbreaks.5 The final questions were decided using a consensus 
method and the scale was kept balanced in terms of questions spanning 
all aspects of the 2001 WHO International Classification of Functioning, 
Disability and Health (ICF) framework.6 The scale also allows directing 
patients to appropriate interventions based on severity of symptoms 
scored on the scale.7
We conducted the UK’s first COVID-19 follow-up study investigating 
100 patients discharged from hospital using a version of the C19-YRS 
scale to capture symptoms and rehabilitation needs.8 This study provided 
the content validity of the scale in that it captured and measured 
persistent symptoms reported in other studies.9,10 Fatigue, breathless-
ness, psychological symptoms, pain and cognitive problems were the 
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most common problems at seven weeks after 
hospital discharge. The findings of the above 
study prompted Leeds Clinical Commissioning 
Group (CCG) to invest in setting up a dedi-
cated COVID rehabilitation service. This was 
the UK’s first dedicated specialist service and is 
currently the benchmark service for other UK 
centres setting up their services. The central 
theme of this service is a comprehensive 
assessment of the individual, which is done 
using the C19-YRS scale. The scale guides 
person specific management and interven-
tions based on severity of problems reported 
on the scale.
C-19 YRS is currently the only scale reported 
in the literature that can capture these symp-
toms and grade the severity of symptoms and 
no other outcome measures currently meas-
ures both the symptom severity and functional 
disability in LC. NHS England has recently 
invested £20 million in setting up 40 LC centres 
(clinics) to assess and manage patients with 
LC; recommending the use of C19-YRS at 
first assessment, six weeks and six months to 
monitor progress.11 The use of the scale has 
been also been recommended in the NICE 
rapid guidelines.1 
With the growing number of cases of LC, 
there was a need for a patient self-report 
version of the scale that could be completed 
without clinician support. There was also a 
need for a digital format to reduce administra-
tive burden and enable real time communica-
tion of findings to the LC MDT.
Aims 
To describe the development of the self-re-
port version and the digital version of the 
C19-YRS and to discuss the scale subsections 
of symptom severity, functional disability and 
overall health status.   
Methods
A multidisciplinary team of physiotherapists, 
occupational therapists, rehabilitation phys-
icians, researchers and a psychometrician 
has been involved in an iterative develop-
ment of the self-report version of the C19-YRS. 
Important persistent symptoms (that define 
rehabilitation needs) reported in studies that 
have included non-hospitalised patients have 
also been considered.
The development of the self-report C19-YRS 
involved rephrasing some items of the original 
telephone C19-YRS to enable patients to 
respond to the questions on their own without 
needing a clinician to complete the responses. 
Items were reordered to separately group the 
items relating to symptoms, and the items 
relating to functional disability. Six additional 
items relating to symptoms were added based 
on emerging evidence reported by patients 
and clinical experience of authors. 
Six individuals with Post-COVID syndrome 
completed the self-report C19-YRS and their 
feedback on content was incorporated in 
this new version of the C19-YRS.  Specialists 
from Speech and Language therapy, dietitians, 
psychologists, Respiratory Medicine and 
Intensive Care Medicine were also consulted 
during the scale development process. The 
emphasis remained on keeping the scale as 
brief and comprehensive as possible, without 
placing undue burden on the respondent 
(patient). 
The final list of main problems included 
in the self-report or digital C19-YRS included 
breathlessness, cough/voice, swallowing/
nutrition, fatigue, continence, cognition, pain/
discomfort, anxiety, depression, post-traumatic 
stress disorder, communication, mobility, 
personal care, activities of daily living, social 
role, perceived health status and family/carers 
views. 
The digital format of the self-report scale 
was developed by a private health company 
called ELAROS. The content of the digital 
format is the same as the self-report paper/ 
electronic version difference only in the user 
interface and layout.
Self-report C19-YRS version
The scale can be completed independently 
by each individual or, if the individual prefers, 
by a clinician via telephone or face-face 
consultation, or with support from their family 
members or carers. It can be completed on 
paper or in electronic document format. There 
are 15 questions capturing the main problems, 
each with either yes/no response options and/
or ordinal scale 0-10 severity grading. The 
respondents at first assessment are also asked 
to compare their symptoms before COVID if 
applicable (Figure 1). Symptom severity can 
be considered mild if less than 3, moderate 
3-5, severe 6 or more.
Questions 1-10 relate to the severity of 
the symptoms and questions 11-15 relate to 
the functional disability experienced by the 
individual. An additional six symptoms are 
placed towards the end of the scale, capturing 
severity of symptoms at the moment without 
pre-COVID severity. These symptoms will be 
tested in ongoing studies and will be incorpor-
ated into the core symptoms section if they are 
found to be clinically appropriate.
Digital format of C19-YRS
The digital C19-YRS uses a patient-facing app 
that captures symptoms and transfers this data 
safely, securely and in real-time to a web portal 
which can be remotely accessed by clinicians. 
The digital C19-YRS will also include extensive 
reporting tools to support health organisations 
to better deploy, gather evidence and account 
for the complex mix of resources utilised for 
these patients.
The app can be used by the patients and 
families to monitor progress in symptoms 
and provide reassurance on their progress (a 
radar splat graph of shrinking or expanding 
LC will be generated by the app) (Figures 1 
and 2). This real time feedback is extremely 
important given the nature of symptoms and 
lack of professional contact during the lock-
down measures. The patient can also be in the 
control of tracking daily and weekly fluctua-
Figure 1: Digital display of C19-YRS scores on the application.
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tions of symptoms which can support planning 
of their daily routine (such as pacing for fatigue 
management).
Discussion
The self-report C19-YRS, and its digital format, 
captures the severity of the main persistent 
symptoms and functional disability in individ-
uals with Long Covid or Post-COVID syndrome. 
The 0-10 likert scale of the items enables 
monitoring of problems across different time 
points of the condition, and can capture the 
impact of interventions used in the manage-
ment of the condition. The digital format of 
the scale allows users to track their condition 
in time and provides them with a quantitative 
assessment of improvement or deterioration of 
LC which is crucial in the management given 
lack of frequent human contact during the 
pandemic. Clinicians are able to monitor the 
patient’s progress using the web-based clinical 
portal. Healthcare services can evaluate their 
treatment programmes using the digital system. 
National comparison of LC data can be under-
taken while assessing the influence of indi-
vidual demographics and illness characteristics 
on LC symptoms. International standardisation 
of defining and quantifying the condition will 
also help towards developing clinical diag-
nostic criteria for the condition.
Mapping of scale to the ICF framework
The World Health Organisation (WHO)’s 
International Classification of Functioning, 
Disability and Health (ICF) provides us with 
a framework to understand the relationship 
between different aspects of any health condi-
tion.6  The domains covered by the self-report 
C19-YRS when mapped to the components of 
ICF (Figure 3) shows that there is satisfactory 
capture of all the components (body functions 
and structures, activities, participation, environ-
mental factors and personal factors) making it 
suitable for a comprehensive biopsychosocial 
assessment. 
Further research
Our future work with the scale will involve 
further validation of the use of the self-report 
version of C19-YRS (and its digital format) in 
the LC population. We will assess the construct 
validity of the scale, and whether the symptoms 
included in the self-report version adequately 
capture the burden in the individual. We will 
estimate whether the measure shows changes 
in the condition (responsiveness) and can be 
used by patients and clinicians to monitor 
effect of interventions, along with picking 
up the natural daily and weekly fluctuations 
of the condition. This can also estimate how 
effectively the measure captures differences 
between individuals, and changes over time 
within the individual. The floor and ceiling 
effects of the measure will be assessed to 
establish the active measurement range of the 
scale, and we will estimate how effectively the 
measure captures small differences between 
individuals at either end of the clinical spec-
trum of the condition. We will also evaluate 
the respondent burden of completing the 
measure within the population, and we will 
assess the use of digital tools, which can 
be challenging in certain cohorts (such as 
those with cognitive problems and those 
who do not use smartphones). The scale will 
undergo further gold-standard psychometric 
testing (through Rasch analysis) to further 
refine the scale and determine its validity 
as an outcome measure for monitoring the 
condition.
The C19-YRS self-report version/ digital 
format is currently being used by at least 20 
UK NHS Trusts in their LC centres to assess and 
monitor the LC symptoms. This provides us with 
an opportunity to pool data and undertake big 
data analysis to undertake a robust analysis 
of psychometric properties. There is also an 
opportunity to explore whether it could be 
developed to a preference based measure and 
undertake an economic evaluation of resource 
use and QALY analysis. The findings of this 
further research is likely to influence local 
policy, commissioning and service delivery that 





Fig 2. Clinician web postal display of scores compared to before COVID 
Figure 2: Clinician web postal display of scores compared to before COVID.
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Download the self-report C19-YRS
Appendix 1. The C19-YRS self-report version (for first assessment) 
https://acnr.co.uk/wp-content/uploads/2021/04/Appendix-I-Self-report-C19-YRS-first-assessment.docx
Appendix 2. The C19-YRS self-report version (for subsequent assessments)
https://acnr.co.uk/wp-content/uploads/2021/04/Appendix-II-Self-report-C19-YRS-subsequent-assessments-.docx
UoL weblink for the scale  
https://licensing.leeds.ac.uk/product/c19-yrs-covid-19-yorkshire-rehabilitation-scale
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